1 The severity of psoriasis is profound as it includes physical and psychological components. Psoriasis is an immune-mediated, chronic relapsing inflammatory condition characterised by abnormal differentiation and proliferation of the epidermis affecting skin, nails and joints. Moreover, the long-term benefit of tildrakizumab on physicians' satisfaction and partners' lives of patients with psoriasis will be evaluated. This study will assess the effect of tildrakizumab, an interleukin-23p19 inhibitor, on the overall well-being of patients with moderate-to-severe psoriasis. Moreover, while drug innovations became available for psoriasis, data on the impact of these therapies on patients’ lives and their closest environment (family, physicians) are limited. In contrast, the well-established 5-item WHO Well-being Index (WHO-5) assesses the subjective psychological well-being of patients. However, the most commonly used decision-making tools in psoriasis, Psoriasis Area and Severity Index (PASI), Physician Global Assessment (PGA) and Dermatology Life Quality Index (DLQI), do not fully capture the impact of psoriasis on patients’ lives. Introduction Psoriasis is a chronic inflammatory skin disease that negatively impacts the quality of life of patients and their families.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |